Elevance Health Inc. carries a market capitalization of 85.33B, placing it among publicly traded companies globally. Its enterprise value stands at 80.27B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 85.33B |
| Enterprise Value | 80.27B |
Elevance Health Inc. currently has 216.84M shares outstanding.
| Shares Outstanding | 216.84M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Elevance Health Inc. trades at a trailing price-to-earnings ratio of 17.13. The price-to-sales ratio is 0.42, and the price-to-book ratio stands at 2.32.
| PE Ratio | 17.13 |
| PS Ratio | 0.42 |
| PB Ratio | 2.32 |
| P/TBV Ratio | 14.92 |
| P/FCF Ratio | 9.89 |
| P/OCF Ratio | 11.39 |
| EV / Sales | 0.40 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 8.15 |
| Current Ratio | N/A |
| Quick Ratio | N/A |
| Debt / Equity | 68.95 |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
| Return on Equity (ROE) | 13.74 |
| Return on Assets (ROA) | 4.00 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 9.26 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Over the trailing twelve months, Elevance Health Inc. has paid 915.00M in income taxes, reflecting an effective tax rate of 15.61.
| Income Tax | 915.00M |
| Effective Tax Rate | 15.61 |
Elevance Health Inc.'s stock has gained approximately 42.31868% over the past 52 weeks. The 50-day moving average sits at 398.62, while the 200-day moving average is 350.07.
| Beta (5Y) | N/A |
| 52-Week Price Change | 42.31868% |
| 50-Day Moving Average | 398.62 |
| 200-Day Moving Average | 350.07 |
| Average Volume (20 Days) | N/A |
Over the trailing twelve months, Elevance Health Inc. generated 201.11B in revenue and converted that into 4.96B in net income, yielding earnings per share of 22.39.
| Revenue | 201.11B |
| Gross Profit | N/A |
| Operating Income | N/A |
| Pretax Income | 5.86B |
| Net Income | 4.96B |
| EBITDA | N/A |
| EBIT | N/A |
| Earnings Per Share (EPS) | 22.39 |
Elevance Health Inc. holds 35.95B in cash and equivalents against 31.04B in total debt, resulting in a net debt position of 20.81B.
| Cash & Cash Equivalents | 35.95B |
| Total Debt | 31.04B |
| Net Debt | 20.81B |
| Equity (Book Value) | 36.68B |
| Book Value Per Share | 166.80 |
| Working Capital | N/A |
Elevance Health Inc. produced 7.46B in operating cash flow over the past twelve months. After subtracting -1.17B in capital expenditures, free cash flow totaled 6.29B - equivalent to 28.60 per share.
| Operating Cash Flow | 7.46B |
| Capital Expenditures | -1.17B |
| Free Cash Flow | 6.29B |
| FCF Per Share | 28.60 |
Elevance Health Inc. operates with a gross margin of 100.00, reflecting its pricing power and cost economics.
| Gross Margin | 100.00 |
| Operating Margin | N/A |
| Pretax Margin | 2.91 |
| Profit Margin | 2.47 |
| EBITDA Margin | N/A |
The company's payout ratio of 30.56 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 6.85 |
| Dividend Yield | N/A |
| Payout Ratio | 30.56 |
| Shareholder Yield | 4.15 |
| FCF Yield | 10.11 |
Elevance Health Inc.'s most recent stock split took place on June 1, 2005 with a 1:2 split ratio.
| Last Split Date | 6/1/2005 |
| Split Ratio | 1:2 |
Elevance Health Inc. posts an Altman Z-Score of 3.52, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 3.52 |